Helicobacter bilis: bacterial provocateur orchestrates host immune responses to commensal flora in a model of inflammatory bowel disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

21 citing papers in PubMed.

1. Eliminating murine norovirus, Helicobacter hepaticus, and intestinal protozoa by embryo transfer for an entire mouse barrier facility.Experimental animals · 2022
   Article
2. Vertical transmission of attaching and invasive E. coli from the dam to neonatal mice predisposes to more severe colitis following exposure to a colitic insult later in life.PloS one · 2022
   Article
3. BioMed research international · 2022
   Review
4. Cytolethal distending toxin: from genotoxin to a potential biomarker and anti-tumor target.World journal of microbiology & biotechnology · 2021
   Review
5. Infection withPathogens (Basel, Switzerland) · 2020
   Article
6. Complex Microbiota in Laboratory Rodents: Management Considerations.ILAR journal · 2020
   Article
7. Zhidai Decoction Inhibits Cervical Cancer through Regulation of Vaginal Microbiota.Evidence-based complementary and alternative medicine : eCAM · 2020
   Article
8. Interactions of Segmented Filamentous Bacteria (Candidatus Savagella) and bacterial drivers in colitis-associated colorectal cancer development.PloS one · 2020
   Article
9. Mouse Models Of Helicobacter Infection And Gastric Pathologies.Journal of visualized experiments : JoVE · 2018
   Article
10. Microbiota and reproducibility of rodent models.Lab animal · 2017
    Review
11. Differing Complex Microbiota Alter Disease Severity of the IL-10Frontiers in microbiology · 2017
    Article
12. The Cytolethal Distending Toxin Contributes to Microbial Virulence and Disease Pathogenesis by Acting As a Tri-Perditious Toxin.Frontiers in cellular and infection microbiology · 2016
    Review
13. Association between Helicobacter spp. infections and hepatobiliary malignancies: a review.World journal of gastroenterology · 2015
    Review
14. Manipulating the Gut Microbiota: Methods and Challenges.ILAR journal · 2015
    Review
15. Characterization of the cytolethal distending toxin (typhoid toxin) in non-typhoidal Salmonella serovars.Gut pathogens · 2015
    Article
16. Helicobacter bilis gamma-glutamyltranspeptidase enhances inflammatory stress response via oxidative stress in colon epithelial cells.PloS one · 2013
    Article
17. Microbial and histopathologic considerations in the use of mouse models of inflammatory bowel diseases.Inflammatory bowel diseases · 2012
    Review
18. Evidence for conserved function of γ-glutamyltranspeptidase in Helicobacter genus.PloS one · 2012
    Article
19. Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages.Microbiology (Reading, England) · 2011
    Review
20. The role of infection in the aetiology of inflammatory bowel disease.Journal of gastroenterology · 2010
    Review

Corrections and comments

• Comment on
  Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice.2007

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as